Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Marksans Pharma Ltd

NSE: MARKSANS · BSE: 524404 · Pharmaceuticals & Biotechnology · 30 announcements

Share price
₹324.40
Market cap
₹14,701 Cr
Revenue (annual)
₹2,951 Cr
Net profit (annual)
₹417.9 Cr
P/E (TTM)
28.4×Sector 47.4×
Promoter holding
43.87%+0.00% QoQ
FII holding
17.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:47 IST BSE
Business Update

Marksans Pharma Business Update

Marksans Pharma Ltd submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The filing details operational and sustainability metrics.